Pro Share Advisors LLC Spring Works Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$48.7 Billion
Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 21,336 shares of SWTX stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,336

Previous 18,262 16.83%

Holding current value

$1 Million

Previous $805,000 24.47%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$34.43 - $46.99 $105,837 - $144,447	3,074 Added 16.83%	21,336 $1 Million
Q1 2025 May 08, 2025	SELL	$32.5 - $59.93 $150,182 - $276,936	-4,621 Reduced 20.19%	18,262 $805,000
Q4 2024 Feb 13, 2025	BUY	$28.61 - $42.55 $157,440 - $234,152	5,503 Added 31.66%	22,883 $826,000
Q3 2024 Nov 13, 2024	BUY	$32.04 - $42.76 $116,337 - $155,261	3,631 Added 26.41%	17,380 $556,000
Q2 2024 Aug 13, 2024	SELL	$36.06 - $47.62 $134,287 - $177,336	-3,724 Reduced 21.31%	13,749 $517,000
Q1 2024 May 08, 2024	BUY	$36.5 - $52.5 $86,432 - $124,320	2,368 Added 15.68%	17,473 $860,000
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $65,153 - $128,105	3,440 Added 29.49%	15,105 $551,000
Q3 2023 Nov 13, 2023	BUY	$23.12 - $31.38 $924 - $1,255	40 Added 0.34%	11,665 $269,000
Q2 2023 Aug 10, 2023	BUY	$23.15 - $32.71 $70,700 - $99,896	3,054 Added 35.63%	11,625 $304,000
Q1 2023 May 11, 2023	SELL	$24.97 - $34.05 $30,538 - $41,643	-1,223 Reduced 12.49%	8,571 $220,000
Q4 2022 Feb 02, 2023	BUY	$21.73 - $28.72 $39,483 - $52,184	1,817 Added 22.78%	9,794 $254,000
Q3 2022 Nov 04, 2022	BUY	$24.1 - $39.66 $192,245 - $316,367	7,977 New	7,977 $227,000
Q2 2022 Aug 01, 2022	SELL	$18.36 - $60.07 $194,285 - $635,660	-10,582 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$48.97 - $65.46 $133,786 - $178,836	-2,732 Reduced 20.52%	10,582 $597,000
Q4 2021 Feb 08, 2022	SELL	$53.3 - $75.84 $49,195 - $70,000	-923 Reduced 6.48%	13,314 $826,000
Q3 2021 Nov 12, 2021	SELL	$62.66 - $88.26 $134,906 - $190,023	-2,153 Reduced 13.14%	14,237 $903,000
Q2 2021 Aug 13, 2021	BUY	$67.45 - $85.63 $215,300 - $273,330	3,192 Added 24.19%	16,390 $1.35 Million
Q1 2021 May 14, 2021	BUY	$65.1 - $93.59 $22,589 - $32,475	347 Added 2.7%	13,198 $971,000
Q4 2020 Feb 09, 2021	BUY	$48.36 - $77.92 $621,474 - $1 Million	12,851 New	12,851 $932,000

Others Institutions Holding SWTX

# of Institutions

265

Shares Held

71.9M

Call Options Held

11.8M

Put Options Held

1.27M

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.93B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Spring Works Therapeutics, Inc. Transaction History